Chemomab Therapeutics Ltd (STU:2QV0)
€ 1.68 0.1 (6.33%) Market Cap: 31.68 Mil Enterprise Value: 13.66 Mil PE Ratio: 0 PB Ratio: 1.92 GF Score: 33/100

Q2 2022 Chemomab Therapeutics Ltd Earnings Call Transcript

Aug 12, 2022 / 12:00PM GMT
Release Date Price: €3.64 (+7.69%)
Operator

Greetings. Welcome to Chemomab Therapeutics 2022 second-quarter earnings call. (Operator Instructions) Please note that this conference is being recorded. I'll now turn the conference over to Barbara Lindheim, Consulting Vice President, Strategic Communications. Barbara, you may now begin.

Barbara Lindheim
Chemomab Therapeutics, Ltd. - Consulting VP, Strategic Communications

Welcome to the Chemomab Therapeutics 2022 second-quarter conference call. Thank you for attending. I am Barbara Lindheim, Consulting Vice President of Strategic Communications at Chemomab. With me today are Dale Pfost, our Chairman and CEO; Don Marvin, CFO, Chief Operating Officer, and Executive Vice President; Dr. David Weiner, Interim CMO; and Dr. de Moura, our Co-Founder and Chief Scientific Officer.

Before turning the call over to Dale, please take note of our forward-looking statements. Today's call may contain forward-looking statements, which may be identified by words such as may, could, will, expect, intend, plan, and other similar words and expressions.

All

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot